Antiviral Therapy

Papers
(The H4-Index of Antiviral Therapy is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Evaluation of doravirine-based regimen population target in a large Italian clinical center24
Commentary: Development of Therapeutics for Congenital Cytomegalovirus Infection23
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective14
A baseline model including quantitative anti-HBc to predict response of peginterferon in HBeAg-positive chronic hepatitis B patients14
The making of the one pill—Developing single tablet regimens for HIV and for HCV13
Treatment-related early discontinuations and adverse events among newly diagnosed people living with HIV initiating integrase inhibitors in a real-world setting13
Low prevalence of doravirine-associated resistance mutations among polish human immunodeficiency-1 (HIV-1)–infected patients12
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants12
Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation12
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts10
Commentary: John C. Martin (1951–2021)10
0.042424917221069